BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

908 related articles for article (PubMed ID: 23357756)

  • 1. Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.
    Cantó C; Sauve AA; Bai P
    Mol Aspects Med; 2013 Dec; 34(6):1168-201. PubMed ID: 23357756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue NAD
    Jokinen R; Pirnes-Karhu S; Pietiläinen KH; Pirinen E
    Redox Biol; 2017 Aug; 12():246-263. PubMed ID: 28279944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity.
    Wencel PL; Lukiw WJ; Strosznajder JB; Strosznajder RP
    Mol Neurobiol; 2018 Jun; 55(6):4612-4623. PubMed ID: 28698968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new facet of ADP-ribosylation reactions: SIRTs and PARPs interplay.
    Faraone-Mennella MR
    Front Biosci (Landmark Ed); 2015 Jan; 20(3):458-73. PubMed ID: 25553461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles.
    Yeong KY; Tan SC; Mai CW; Leong CO; Chung FF; Lee YK; Chee CF; Abdul Rahman N
    Chem Biol Drug Des; 2018 Jan; 91(1):213-219. PubMed ID: 28719017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Clickable NAD
    Zhang L; Lin H
    Methods Mol Biol; 2017; 1608():95-109. PubMed ID: 28695506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity.
    Pillai JB; Isbatan A; Imai S; Gupta MP
    J Biol Chem; 2005 Dec; 280(52):43121-30. PubMed ID: 16207712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arabidopsis sirtuins and poly(ADP-ribose) polymerases regulate gene expression in the day but do not affect circadian rhythms.
    Kim JH; Bell LJ; Wang X; Wimalasekera R; Bastos HP; Kelly KA; Hannah MA; Webb AAR
    Plant Cell Environ; 2021 May; 44(5):1451-1467. PubMed ID: 33464569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
    Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the function and regulation of ADP-Ribosylation.
    Hottiger MO; Boothby M; Koch-Nolte F; Lüscher B; Martin NM; Plummer R; Wang ZQ; Ziegler M
    Sci Signal; 2011 May; 4(174):mr5. PubMed ID: 21610250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP is involved in replicative aging in Neurospora crassa.
    Kothe GO; Kitamura M; Masutani M; Selker EU; Inoue H
    Fungal Genet Biol; 2010 Apr; 47(4):297-309. PubMed ID: 20045739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.
    Carter-O'Connell I; Cohen MS
    Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
    Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
    Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin.
    Benavente CA; Schnell SA; Jacobson EL
    PLoS One; 2012; 7(7):e42276. PubMed ID: 22860104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD+ and NADH in cellular functions and cell death.
    Ying W
    Front Biosci; 2006 Sep; 11():3129-48. PubMed ID: 16720381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD+ metabolism and NAD(+)-dependent enzymes: promising therapeutic targets for neurological diseases.
    Ma Y; Chen H; He X; Nie H; Hong Y; Sheng C; Wang Q; Xia W; Ying W
    Curr Drug Targets; 2012 Feb; 13(2):222-9. PubMed ID: 22204321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuins and their interactions with transcription factors and poly(ADP-ribose) polymerases.
    Jęśko H; Strosznajder RP
    Folia Neuropathol; 2016; 54(3):212-233. PubMed ID: 27764514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?
    Zhang J
    Bioessays; 2003 Aug; 25(8):808-14. PubMed ID: 12879452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis.
    Podyacheva E; Toropova Y
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose). The most elaborate metabolite of NAD+.
    Bürkle A
    FEBS J; 2005 Sep; 272(18):4576-89. PubMed ID: 16156780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.